Bahareh Rasouli

Bahareh Rasouli is a Research Scientist in the Therapeutics and Infectious Disease Epidemiology group at the Department of Population Medicine at Harvard Pilgrim Health Care Institute and Harvard Medical School. She primarily works on the FDA-sponsored Sentinel Initiative, where she contributes to projects evaluating the safety and performance of medical products.

Dr. Rasouli completed her MSc in public health nutrition and, subsequently, a Ph.D. in diabetes epidemiology at Karolinska Institutet, Sweden. Her doctoral thesis is about lifestyle and genetic risk factors for LADA-latent autoimmune diabetes in adults. Following that, she was a postdoc researcher at the Harvard School of Public Health, where her research focused primarily on developing and applying trial emulation approaches using observational data for comparative effectiveness research.